NCT04297449 is a clinical trial in Osteochondritis Dissecans, sponsored by Hannover Medical School.

Who is sponsoring NCT04297449?

NCT04297449 is sponsored by Hannover Medical School.

What condition does NCT04297449 study?

NCT04297449 studies Osteochondritis Dissecans.

Is NCT04297449 still recruiting?

NCT04297449 is currently completed. Last updated 16 September 2021.

Last reviewed 2021-09-16 · How we verify

NCT04297449

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prospective 2-year Data Collection of the First 10 Patients After Ankle Spacer Implantation

Completed Last updated 16 September 2021

What this trial tests

trial in Osteochondritis Dissecans in 8 participants. Completed in 3 September 2021.

Timeline

18 January 2019

Primary endpoint
19 January 2021

3 September 2021

Quick facts

Lead sponsor	Hannover Medical School
Status	Completed
Study type	OBSERVATIONAL
Enrollment	8
Start date	18 January 2019
Primary completion	19 January 2021
Estimated completion	3 September 2021
Sites	1 location across Germany

Conditions studied

Osteochondritis Dissecans — all drugs for Osteochondritis Dissecans →

Sponsor

Hannover Medical School

Who can join

Adults 18 to 80, any sex, with Osteochondritis Dissecans. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Osteochondral defects (OCD) of the talus are pathologic lesions of the talar cartilage and its subchondral bone and might severely deteriorate the quality of life. For the treatment of multiple and/or large talar OCDs and in patients with failed previous surgical treatment the Ankle Spacer was developed. Six patients are included in a prospective clinical and radiological study with a follow-up of two years.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Hannover Medical School trials

Trials by the same sponsor.

NCT07384039 — Exercise Training in Patients With Myeloproliferative Neoplasms · NA · not yet recruiting
NCT06740747 — Intermittent Theta-Burst Stimulation to Improve Negative Symptoms and Cognition in Schizophrenia · NA · recruiting
NCT06795516 — Observational Study on the Clinical Use of ex Vivo Lung Perfusion (XPS™) for Lung Transplantation · terminated
NCT06603311 — Finite Treatment of Hepatitis Delta With Bulevirtide: Identification of Biomarkers Associated With Sustained Control of · NA · active not recruiting
NCT06493006 — Promoting Sustainable and Active Mobility Among Employees and Students · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04297449 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hannover Medical School
Last refreshed: 16 September 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04297449.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing